43M — 5.5 months on dutasteride + oral minoxidil. How’s my progress? 8/18/2026
A 43-year-old man has been using dutasteride, oral minoxidil, and ketoconazole shampoo for 5.5 months, seeing improvement in hair density and hairline but still struggling with temple regrowth. He is considering adding microneedling to his routine and is advised to use a depth of 0.5 to 0.75 mm every 10 to 14 days for better results.
View this post in the Community →
Similar Community Posts Join
6 / 6 resultscommunity PROGRESS ON NEW ROUTINE - DUT/Minox/Microneedling
The conversation is about a user's hair loss treatment progress using a routine of Avodart (Dutasteride), oral and topical Minoxidil, Ketoconazole shampoo, and microneedling. The user reports no side effects and shows improvement after resuming consistent treatment.
community M30, month 2 of dutasteride and minoxidil
A user shared their two-month progress using dutasteride, minoxidil, ketoconazole shampoo, and tretinoin cream for hair loss, reporting no side effects and increased sex drive. Other users discussed their experiences with similar treatments, including finasteride and oral minoxidil, and debated the effectiveness of microneedling.
community NW6 - 12 months progress - Dut/Oral Min/2% Keto Shampoo
User shared 12-month hair loss progress using oral minoxidil, oral dutasteride, and 2% ketoconazole shampoo. They detailed their medication regimen and dosages.
community What else to add to my stack? All help extremely appreciated!
The user is using a hair loss treatment regimen including Avodart (dutasteride), oral minoxidil, LLLT caps, vitamins, and ketoconazole shampoo, and is considering adding dermarolling and RU58841. They are experiencing unwanted body hair growth from minoxidil and are planning for a future hair transplant.
community Rich anti-hair loss regimen with poor results
A 23-year-old male has been using a regimen including oral Dutasteride, topical Minoxidil, Azelaic acid gel, Ketoconazole shampoo, and microneedling for 4 months with minimal results. Another user suggests that it typically takes a year to see significant effects and encourages him to continue the routine.
community 20 months on dut and getting worse update
The user has been on dutasteride for 20 months with worsening hair loss and is considering switching back to finasteride, which previously stabilized their hair. They are using a regimen including dutasteride, oral and topical minoxidil, vitamins, and ketoconazole shampoo, and are planning to add microneedling.
Related Research
6 / 6 resultsresearch Male androgenetic alopecia
This review examines male androgenetic alopecia and reports no new clinical results, offering insights to aid dermatologists in making informed therapeutic decisions.
research Androgenetik Alopesi
This review discusses current treatment methods for managing androgenetic alopecia in men and women, but reports no new clinical results, highlighting the lack of a standard treatment guide.
research Sulfotransferase SULT1A1 activity in hair follicle, a prognostic marker of response to the minoxidil treatment in patients with androgenetic alopecia: a review
This review discusses the potential of using SULT1A1 expression in the scalp as a biomarker to predict response to minoxidil treatment for androgenetic alopecia, but reports no new clinical results.
research A Canadian Consensus on Androgenetic Alopecia: Approach and Management
This expert panel review developed consensus recommendations for managing androgenetic alopecia in Canadian adults, endorsing seven interventions like oral and topical medications and platelet-rich plasma.
research Managing patterned hair loss – a hair raising task!
This review summarizes existing knowledge on diffuse and patterned alopecia, emphasizing recent advancements in treatment beyond FDA-approved options, but it reports no new clinical findings.
research Treat androgenetic alopecia with antiandrogens, as well as other pharmacological and non-pharmacological interventions
This review discusses current treatment options for androgenetic alopecia, noting that most lack robust evidence for efficacy and safety, highlighting the need for more comprehensive studies.